Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial)
- Abstract
- Background: Bulky or multiple lymph node (LN) metastases are associated with poor prognosis in cervical cancer, and the size or number of LN metastases is not yet reflected in the staging system and therapeutic strategy. Although the therapeutic effects of surgical resection of bulky LNs before standard treatment have been reported in several retrospective studies, well-planned randomized clinical studies are lacking. Therefore, the aim of the Korean Gynecologic Oncology Group (KGOG) 1047/DEBULK trial is to investigate whether the debulking surgery of bulky or multiple LNs prior to concurrent chemoradiation therapy (CCRT) improves the survival rate of patients with cervical cancer IIICr diagnosed by imaging tests.
Methods: The KGOG 1047/DEBULK trial is a phase III, multicenter, randomized clinical trial involving patients with bulky or multiple LN metastases in cervical cancer IIICr. This study will include patients with a short-axis diameter of a pelvic or para-aortic LN ≥2 cm or ≥3 LNs with a short-axis diameter ≥1 cm and for whom CCRT is planned. The treatment arms will be randomly allocated in a 1:1 ratio to either receive CCRT (control arm) or undergo surgical debulking of bulky or multiple LNs before CCRT (experimental arm). CCRT consists of extended-field external beam radiotherapy/pelvic radiotherapy, brachytherapy and LN boost, and weekly chemotherapy with cisplatin (40 mg/m²), 4-6 times administered intravenously. The primary endpoint will be 3-year progression-free survival rate. The secondary endpoints will be 3-year overall survival rate, treatment-related complications, and accuracy of radiological diagnosis of bulky or multiple LNs.
Trial registration: ClinicalTrials.gov Identifier: NCT05421650; Clinical Research Information Service Identifier: KCT0007137.
- All Author(s)
- Bo Seong Yun
; Kwang-Beom Lee
; Keun Ho Lee
; Ha Kyun Chang
; Joo-Young Kim
; Myong Cheol Lim
; Chel Hun Choi
; Hanbyoul Cho
; Dae-Yeon Kim
; Yun Hwan Kim
; Joong Sub Choi
; Chae Hyeong Lee
; Jae-Weon Kim
; Sang Wun Kim
; Yong Bae Kim
; Chi-Heum Cho
; Dae Gy Hong
; Yong Jung Song
; Seob Jeon
; Min Kyu Kim
; Dae Hoon Jeong
; Hyun Park
; Seok Mo Kim
; Sang-Il Park
; Jae-Yun Song
; Asima Mukhopadhyay
; Dang Huy Quoc Thinh
; Nirmala Chandralega Kampan
; Grace J Lee
; Jae-Hoon Kim
; Keun-Yong Eom
; Ju-Won Roh
; Korean Gynecologic Oncology Group (KGOG) Investigators
- Issued Date
- 2024
- Type
- Article
- Keyword
- Bulky Lymph Node; Cervical Cancer; Concurrent Chemoradiotherapy; Lymph Node Excision; Lymph Node Metastasis; Progression-Free Survival
- Publisher
- 대한부인종양콜포스코피학회
Korean Society of Gynecologic Oncology and Colposcopy
- ISSN
- 2005-0380
; 2005-0399
- Citation Title
- Journal of gynecologic oncology
- Citation Volume
- 35
- Citation Number
- 5
- Citation Start Page
- e57
- Citation End Page
- e57
- Language(ISO)
- eng
- DOI
- 10.3802/jgo.2024.35.e57
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/3483
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.